Carregant...
What have we learned about CKD-MBD From the EVOLVE and PRIMO trials?
PURPOSE OF REVIEW: The treatment of CKD-MBD (Chronic Kidney Disease-Mineral Bone Disorder) has traditionally focused on improvement in biochemical parameters of the disease. However, studies evaluating hard clinical end points or surrogate end points are limited. RECENT FINDINGS: Two randomized tria...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3983668/ https://ncbi.nlm.nih.gov/pubmed/24100218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNH.0b013e328365b3a3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|